These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11154214)
1. Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia. Kearns PR; Pieters R; Rottier MM; Pearson AD; Hall AG Blood; 2001 Jan; 97(2):393-8. PubMed ID: 11154214 [TBL] [Abstract][Full Text] [Related]
2. Raised intracellular glutathione levels correlate with in vitro resistance to cytotoxic drugs in leukaemic cells from patients with acute lymphoblastic leukemia. Maung ZT; Hogarth L; Reid MM; Proctor SJ; Hamilton PJ; Hall AG Leukemia; 1994 Sep; 8(9):1487-91. PubMed ID: 8090028 [TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940 [TBL] [Abstract][Full Text] [Related]
4. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study. Uckun FM; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P Blood; 1997 May; 89(10):3769-77. PubMed ID: 9160683 [TBL] [Abstract][Full Text] [Related]
5. Glutathione in childhood acute leukaemias. Kearns P; Pieters R; Rottier MM; Veerman AJ; Schmiegalow K; Pearson AD; Hall AG Adv Exp Med Biol; 1999; 457():211-6. PubMed ID: 10500796 [TBL] [Abstract][Full Text] [Related]
6. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol]. Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166 [TBL] [Abstract][Full Text] [Related]
7. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia. Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376 [TBL] [Abstract][Full Text] [Related]
8. WT1 protein expression in childhood acute leukemia. Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786 [TBL] [Abstract][Full Text] [Related]
9. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303 [TBL] [Abstract][Full Text] [Related]
10. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Hongo T; Yajima S; Sakurai M; Horikoshi Y; Hanada R Blood; 1997 Apr; 89(8):2959-65. PubMed ID: 9108416 [TBL] [Abstract][Full Text] [Related]
11. Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE). Donadieu J; Auclerc MF; Baruchel A; Perel Y; Bordigoni P; Landman-Parker J; Leblanc T; Cornu G; Sommelet D; Leverger G; Schaison G; Hill C; Br J Cancer; 2000 Dec; 83(12):1617-22. PubMed ID: 11104555 [TBL] [Abstract][Full Text] [Related]
12. De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo. Dervieux T; Brenner TL; Hon YY; Zhou Y; Hancock ML; Sandlund JT; Rivera GK; Ribeiro RC; Boyett JM; Pui CH; Relling MV; Evans WE Blood; 2002 Aug; 100(4):1240-7. PubMed ID: 12149204 [TBL] [Abstract][Full Text] [Related]
13. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance]. Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123 [TBL] [Abstract][Full Text] [Related]
16. Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications. Guglielmi C; Cordone I; Boecklin F; Masi S; Valentini T; Vegna ML; Ferrari A; Testi AM; Foa R Leukemia; 1997 Sep; 11(9):1501-7. PubMed ID: 9305605 [TBL] [Abstract][Full Text] [Related]
17. Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia. Hogarth LA; Hall AG Blood; 1999 Apr; 93(8):2671-8. PubMed ID: 10194447 [TBL] [Abstract][Full Text] [Related]
18. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia. Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644 [No Abstract] [Full Text] [Related]
19. Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children. Matherly LH; Taub JW; Wong SC; Simpson PM; Ekizian R; Buck S; Williamson M; Amylon M; Pullen J; Camitta B; Ravindranath Y Blood; 1997 Jul; 90(2):578-89. PubMed ID: 9226157 [TBL] [Abstract][Full Text] [Related]
20. Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia. von Lintig FC; Huvar I; Law P; Diccianni MB; Yu AL; Boss GR Clin Cancer Res; 2000 May; 6(5):1804-10. PubMed ID: 10815901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]